Enhancement of hepatic glucose release and bile flow by the phosphodiesterase-III-inhibitor enoximone in the perfused rat liver
- 7 April 1995
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 56 (20) , 1721-1726
- https://doi.org/10.1016/0024-3205(95)98579-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Papaverine Inhibits Transcytotic Vesicle Transport and Lipid Excretion Into Bile in Isolated Perfused Rat LiverHepatology, 1992
- Effects of Ca2+ agonists on cytosolic Ca2+ in isolated hepatocytes and on bile secretion in the isolated perfused rat liverHepatology, 1992
- Distribution of cyclic AMP phosphodiesterase in microdissected periportal and perivenous rat liver tissue with different dietary statesHistochemistry and Cell Biology, 1991
- Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesterase peak III inhibitorsThe American Journal of Cardiology, 1989
- Effect of vasodilators on hepatic microcirculation: A study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liverHepatology, 1988
- Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aortaBiochemical Pharmacology, 1986
- Fructose 2,6-bisphosphate 2 years after its discoveryBiochemical Journal, 1982
- Direct Control of Glycogen Metabolism in the Perfused Rat Liver by the Sympathetic InnervationEuropean Journal of Biochemistry, 1982
- Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.Circulation, 1981